QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer
Brings More Than Two Decades of Leadership Experience in the In-Vitro Diagnostics Industry SAN DIEGO–(BUSINESS WIRE)–QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point of care settings, clinical labs and transfusion medicine, announced the Company’s Board of Directors (the “Board”) has appointed Brian J. Blaser as President and Chief Executive Officer (“CEO”) effective May 6. … Continue reading QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer